Marc R. Schneebaum

2018

In 2018, Marc R. Schneebaum earned a total compensation of $3.4M as Senior Vice President, Chief Financial Officer at Synta Pharmaceuticals, a 247% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$222,314
Option Awards$2,748,200
Salary$380,250
Other$15,336
Total$3,366,100

Schneebaum received $2.7M in option awards, accounting for 82% of the total pay in 2018.

Schneebaum also received $222.3K in non-equity incentive plan, $380.3K in salary and $15.3K in other compensation.

Rankings

In 2018, Marc R. Schneebaum's compensation ranked 3,398th out of 14,244 executives tracked by ExecPay. In other words, Schneebaum earned more than 76.1% of executives.

ClassificationRankingPercentile
All
3,398
out of 14,244
76th
Division
Manufacturing
1,256
out of 5,765
78th
Major group
Chemicals And Allied Products
439
out of 2,128
79th
Industry group
Drugs
361
out of 1,817
80th
Industry
Pharmaceutical Preparations
277
out of 1,391
80th

Pay ratio

Marc R. Schneebaum's Pay$3,366,100
Median Employee's Pay$804,000
Pay Ratio

4

to 1

In 2018, the annual total compensation of Marc R. Schneebaum was $3,366,100.

The annual total compensation of the median employee at Synta Pharmaceuticals was $804,000.

The ratio of Marc R. Schneebaum's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on May 15, 2019.

Schneebaum's colleagues

We found two more compensation records of executives who worked with Marc R. Schneebaum at Synta Pharmaceuticals in 2018.

2018

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2018

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like